The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy

Author:

Salati Massimiliano,Caputo Francesco,Cunningham David,Marcheselli Luigi,Spallanzani Andrea,Rimini Margherita,Gelsomino Fabio,Reggiani-Bonetti Luca,Andrikou Kalliopi,Rovinelli Francesca,Smyth Elyzabeth,Baratelli Chiara,Kouvelakis Kyriakos,Kalaitzaki Ria,Gillbanks Angela,Michalarea Vasiliki,Cascinu Stefano,Braconi Chiara

Funder

LILT Modena Onlus

National Institute for Health Research

Biomedical Research Centre

The Royal Marsden NHS Foundation Trust

Institute of Cancer Research

The Institute of Cancer Research (ICR)

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Cholangiocarcinoma: new insights into disease pathogenesis and biology;Braconi;Infect Dis Clin N Am,2010

2. Cancer statistics;Siegel;Ca - Cancer J Clin,2017

3. I numeri del cancro in Italia;AIRTUM Working Group,2018

4. Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise;Saha;Oncol,2016

5. Cholangiocarcinoma;Razumilava;Lancet,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3